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Several N-[2-(substituted phenoxy) acetyl/propionyl]
2-pyrrolidinones have been synthesised and screened for
their antibacterial and antifungal activities. Their struc-
tures have been elucidated on the basis of elemental
analysis and spectral data.
2-Pyrrolidinone is associated with broad spectrum
of biological activities!". On the other hand phe-
noxy/substituted phenoxy acetic/propionic acids
and their derivatives are well known for their bio-
active nature'". Considering the above facts we
report herein the synthesis of the title compounds
2a-t. Substituted phenoxy acids were prepared by
usual method". These acids were then reacted with
SOCl2 to afford substituted phenoxy ace-
tyl/propionyl chlorides, la-t, which on condensa-
tion with 2-pyrrolidinone furnished the desired
products 2a-t (Table I, Scheme I). The structures
of the synthesised compounds were established on
the basis.of their spectral data and elemental analy-
SIS.
Antimicrobial activity
All the compounds were tested in vitro for anti-
bacterial activity" against Shigella dysenteriae,
Streptococcus. aureus and Shigella flexneri at 50
and 100 ppm concentrations using streptomycin as
a standard drug at same concentration for compari-
son (cf. Table II). Antifungal activity was per-
formed against Crysosporium pannical, Aspergil-
lus niger and Rizophus oryzae by filter paper disc
method II at 100 and 500 ppm concentrations using
mycostatin as a standard for comparison (cf ..Table
III).
Note
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Scheme I
The purity of compounds was checked on TLC. IR
spectra were recorded in KBr on an Acculab 10
spectrophotometer (vmax in cm') and IH NMR
spectra in CDC13 on 400 MHz on Bruker WM 400
(chemical shift in & ppm) using TMS as an internal
standard.
2, 4, 6-Tribromophenoxy acetyl chlroide la.
To a solution of 2, 4, 6-tribromophenoxy acetic
acid (0.05 mole in 50 mL CHCI), SOCl2 (0.06
mole) was added, and the mixture was refluxed for
about 6 h on a.boiling water-bath. Excess of SOCl2
was removed under reduced pressure to give com-
pound la, yield 76% (Found: C, 23.48; H, 0.91.
CsH402Br3CI requires C, 23.55; H, 0.98%); IR:
2905 and 1485 (-CH2), 1785 (COCl), 1490 and 700
(substituted phenyl ring), 1245, 1190 and 1175 (C-
O-C); IH NMR: 8.21 (2H, m, Ar-H) and 2.80 (2H,
s, CH2).
Compounds 1b-t were synthesised similarly
from substituted phenoxy acetic/propionic acids.
NOTES
Table !-Physical data of compounds 2a-t
Compd " R X Yield m.p. Mol. formula
(%) eC)
2a H 2,4,6-tribromo 82 89-90 C12HION03Br3
2b H 2,4-dibromo 87 68-69 CI2HIIN03Br2
2c H 2,4,6-trichloro 83 49-50 CI2HION03CI3
2d Me 2,4,6-trichloro 80 82-83 C13H12N03CI3
2e H 2,4-dichloro 65 51-52 C12HIIN03CI2
2f Me 2,4-dichloro 78 111-12 C13H13N03CI2
2g H 2-chloro 75 62-63 CI2H12N03CI
2h Me 2-chloro 72 126-27 C13HI4NOJCI
2i H 4-chloro 81 50-51 CI2HI2NOJCI
2j Me 4-chloro 60 117-18 C13H,4NOJCI
2k H 2-CHJ 73 157-58 C13H'SNOJ
21 Me 2-CHJ 70 57-58 CI4HI7NOJ
2m H 3-CHJ 76 127-28 C13H'SNOJ
20 Me 3-CHJ 81 98-99 CI4H17NOJ
20 H 4-CHJ 66 143-44 C13H'SNOJ
2p Me 4-CHJ 82 134-35 CI4H17NOJ
2q H 2,4,6-trinitro 80 155-56 CI2HION409
2r H 2-nitro 78 87-88 C12HI2N20S
2s H 3-nitro 77 \07-08 C12HI2N20S
2t H 4-nitro 81 177-78 CI2HI2N20S
• All the cnrnpounds gave satisfactory C, H & N analysis.
Table II-Antibacterial activity of compounds 2a-t
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Compd S dysenteriae S aureus Sflexneri
50ppm 100ppm 50ppm 100ppm 50ppm 100 ppm
2a ++ +++ + +++ + +++
2b + ++ + ++ ++ ++
2c ++ +++ +++ +++ ++ ++++
2d +++ ++++ ++ +++ +++ ++++
2e ++ +++ + ++ + ++
2f + + ++ ++ + ++
2g + + + ++
2h + ++ ++ ++ + ++
2i ++ ++ + ++ +
2j + ++ + ++ ++
2k ++ + ++
21 + + + + ++
2m ++ ++ + ++ +
20 ++ ++ + + + ++
20 + + + ++ + ++
2p ++ ++ + ++ ++
2q ++ +++ ++ ++++ ++ ++++
2r ++ +++ + ++ + +++
2s + ++ ++ ++ + ++
2t ++ +++ + ++ + +++
std ++ ++++ ++ ++++ ++ +++
std: Streptomycin, Inhibition zone, (-): Not effective, (+): 6-11 mm, (++): 12-20 mm, (+++): 21-29 mm, (++++): above 30 mm.
N-[2-(2, 4, 6-tribromophenoxy)acetyIJ-2-pyr- (0.029 mole in Me2CO) was added with constant
rolidinone 2a. To an equimolar solution of 2- stirring for about 60 min. The separated residue
pyrrolidinone (0.029 mole in PhCH3-NaOH- was crystallised from chloroform to give 2a, yield
MeOH), 2, 4, 6-tribromophenoxy acetyl chloride 63% (Found: C, 31.52; H, 2.13; N, 3.03.
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Table III-Antifungal activity of compounds 2a-t
Compd C. pannical A. niger R. oryzae
100 ppm 500 ppm 100 ppm 500 ppm 100 ppm 500 ppm
2a + +++ ++ ++++ ++
2b ++ +++ + +++ ++
2c + ++ ++ + ++
2d ++ ++++ + +++ + +++
2e + +++ ++ +++ ++ +++
2f ++ + ++
2g + ++ + ++ +
2h ++ ++ + + ++ ++
2i
2j + + + +
2k + ++ + + + ++
21 + + ++ ++ +++
2m + ++ ++ + ++
2n + ++ + + + ++
20 + + ++
2p + + + ++
2q ++ +++ ++ ++++ + +++
2r + ++ ++ +++ ++ +++
2s + + ++ + ++
2t + ++ ++ ++ +++
std ++ ++++ ++ +++ ++ ++++
std: Mycostatin, Inhibition zone, (-): <II mm; (+):11-14 mm, (++): 15-18 mm, (+++): 19-21 mm, (++++): 22-25 mm.
CizHIO03NBr3 requires C, 31.57; H, 2.19; N,
3.07%); IR 2908 and 1470 (-CH2), 1645 (CON<),
1739, 1693 (carbonyl of lactam), 1245, 1220 and
1165 (C-O-C), 1510 and 700 (substituted phenyl
ring); IH NMR: 8.20 (2H, m, Ar-H), 2.80 (2H, s, -
CHz-CO), 3.25 (2H, s, CHz), 3.20 (2H, t, CHz) and
1.99 (2H, dd, -CHz).
Likewise rest of the compounds 2b-t were syn-
thesised similarly from acetyl and propionyl chlo-
rides (cf. Table I).
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